menu

QuintilesIMS Blog

Fresh ideas and insights from our experts around the globe

distribution
Brazilians flock to pharmacies: How healthcare companies can bolster sales by embracing this shifting shopper trend
Filtered by 'RD' ×
Mark Mozeson
How will the US pharma market evolve during the period 2017-2021?
Read More
Forrest Anthony
Targeted therapies continue to churn out new oncology treatments meeting unmet medical needs among cancer patients around the world.
Read More
Rupert Dixon
How a virtual R&D model is giving small and mid-sized companies the resource to bring their assets to market.
Read More
Barbara Gillespie
How success with migalastat demonstrates the value of using genomic testing criteria across multiple disease categories.
Read More
Jeff Keefer
How patient reported outcomes and global trials are giving new hope to sickle cell disease patients who haven’t seen a new treatment in decades.
Read More
PatrickJordan
In the new era of clinical development, decisions are all data driven, and the mistakes that add millions of dollars to drug development projects will soon be a distant memory.
Read More
Stephen Evans
Selecting the right commercial site for an early phase trial.
Read More
Brad Smith
Terry Murdock
How checkpoint inhibitors help targeted cancer therapies reach their destination – better patient outcomes.
Read More
Sylvie Dupin